Type 2 & other diabetes

Sex and Socioeconomic Differences in the Initiation of SGLT2 Inhibitors and GLP ‐1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort Study

Diabetes Obes MetabPublished Nationwide cohort study

Authors' conclusion

Among individuals with newly diagnosed T2D and CVD, lower initiation of guideline-recommended cardioprotective GLDs was observed among individuals with low socioeconomic status in both men and women.

Study context

Population
Individuals with newly diagnosed concomitant T2D and cardiovascular disease (CVD), Denmark, 2015–2022; 37% women37% women
Participants
81,361 individuals
Exposure
Initiation of cardioprotective glucose-lowering drugs (GLDs) by sex and socioeconomic status
Outcome
Initiation of cardioprotective GLDs (SGLT2i and GLP-1 RA)
Methodological detailsregistry-based, Danish health registries
  • Registry-based
  • Danish health registries

Main finding

As reported in the abstract

Initiation of cardioprotective GLDs by occupational status
Incidence rate ratio (95% CI)
Unemployed womenvs Employed women
0.81(0.75–0.88)
Retired womenvs Employed women
0.88(0.79–0.97)
Unemployed menvs Employed men
0.77(0.73–0.81)
Retired menvs Employed men
0.83(0.78–0.88)

Observational data: associations, not effects.

Further findings

Initiation by educational level

IRR, females
0.95 (95% CI: 0.86-1.05)
IRR, males
1.00 (95% CI: 0.94-1.07)
Crude initiation rates per 1000 person-years increased with higher educational level; gradient disappeared after multivariable adjustment

Initiation by marital status

Divorced, widowed and unmarried individuals had lower IRR than married individuals

Original publication

Sex and Socioeconomic Differences in the Initiation of SGLT2 Inhibitors and GLP ‐1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort Study. Diabetes Obes Metab. Published 20 September 2026. doi:10.1111/dom.71334

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.